GlobeImmune Inc. | |
Stock Exchange | Other OTC |
EPS |
- |
Market Cap |
$2 M |
Shares Outstanding |
5.75 M |
Public Float |
- |
Address |
1450 Infinite Drive Louisville Colorado 80027 United States |
Employees | - |
Website | http://www.globeimmune.com |
Updated | 07/08/2019 |
GlobeImmune, Inc. is a biopharmaceutical company. It engages in developing therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform. The company was founded by Donald Bellgrau, Richard C. |